1-1 of 1
Albertine Donker
Close
Sort by
Journal Articles

Preliminary Results of a Phase-2 Clinical Trial of the ALK-2 Inhibitor Ker-047 for Treatment of Iron Refractory Iron Deficiency Anemia

Vera Hoving, Albertine Donker, Enrikas Vainorius, Harveen Dhillon Natarajan, Jenn Lachey, Simon Cooper, Dorine W. Swinkels, Saskia Schols
Journal: Blood
Blood (2022) 140 (Supplement 1): 2475–2476.
https://doi.org/10.1182/blood-2022-163698
Published: 2022